Viewing Study NCT00045266


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2025-12-28 @ 1:08 PM
Study NCT ID: NCT00045266
Status: COMPLETED
Last Update Posted: 2016-06-03
First Post: 2002-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult Burkitt lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV mantle cell lymphoma View
None unspecified adult solid tumor, protocol specific View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View